CNCR

Loncar Cancer Immunotherapy ETF

Up$23.31
+$0.05
(+0.21%)
As of 12:58:38 PM EDT | 1/22/20  |  Market Open

CNCR Trading Data

Open

$23.35

Low Price

$23.31

High Price

$23.5

Previous Last Price

$23.26

Bid Size

$23.29 X 700

Ask Size

$23.33 X 800

CNCR Portfolio Data

AUM

$38,379,000

Shares

1,650

PE Ratio

0

Price / Book Ratio

3.98

Expense Ratio

0.79

Net Asset Value

$23.26

Volume

Volume

1,965

Avg. Volume (YDT)

13,924

Dollar Volume

$475,313

Weekly Avg. Volume

5,847

Monthly Avg. Volume

14,597

Quarterly Avg. Volume

17,141

CNCR Fund Description

The Loncar Cancer Immunotherapy ETF seeks investment results that correspond generally to the price and yield per for mance, before fees and expenses, of the Loncar Cancer Immunotherapy Index.

CNCR Chart

CNCR Summary

Fund Family

Exchange Traded Concepts

Tracks This Index

Loncar Cancer Immunotherapy ETF

Inception Date

2015-10-15

Asset Class

Equity

Asset Class Size

Biotech

CNCR Classification

Region (General)

Global

Region (Specific)

Sector

Health Care

Equity Index

Leveraged Family

CNCR Holdings

Top 10 Holdings

FATE THERAPEUTICS INC (FATE)
5.26%
BLUEBIRD BIO INC (BLUE)
4.55%
ZYMEWORKS INC (ZYME)
4.47%
CELLECTIS S A (CLLS)
4.43%
MODERNA INC (MRNA)
4.33%
BIONTECH SE (BNTX)
4.32%
PRECISION BIOSCIENCES INC (DTIL)
4.27%
ASTRAZENECA PLC (AZN)
4.15%
BRISTOL MYERS SQUIBB CO (BMY)
4.07%
NEKTAR THERAPEUTICS (NKTR)
4.03%

Total CNCR Holdings

Total Holdings: 27

FATE THERAPEUTICS INC (FATE)
5.26%
BLUEBIRD BIO INC (BLUE)
4.55%
ZYMEWORKS INC (ZYME)
4.47%
CELLECTIS S A (CLLS)
4.43%
MODERNA INC (MRNA)
4.33%
BIONTECH SE (BNTX)
4.32%
PRECISION BIOSCIENCES INC (DTIL)
4.27%
ASTRAZENECA PLC (AZN)
4.15%
BRISTOL MYERS SQUIBB CO (BMY)
4.07%
NEKTAR THERAPEUTICS (NKTR)
4.03%
REGENERON PHARMACEUTICALS (REGN)
4.02%
Y MABS THERAPEUTICS INC (YMAB)
3.96%
MERCK & CO INC (MRK)
3.96%
XENCOR INC (XNCR)
3.91%
ARGENX SE (ARGX)
3.86%
NEXTCURE INC (NXTC)
3.82%
AUTOLUS THERAPEUTICS PLC (AUTL)
3.74%
BEIGENE LTD (BGNE)
3.69%
IOVANCE BIOTHERAPEUTICS INC (IOVA)
3.68%
ATARA BIOTHERAPEUTICS INC (ATRA)
3.67%
GILEAD SCIENCES INC (GILD)
3.63%
MORPHOSYS AG (MOR)
3.58%
ZIOPHARM ONCOLOGY INC (ZIOP)
3.57%
ALLOGENE THERAPEUTICS INC (ALLO)
3.56%
CRISPR THERAPEUTICS AG (CRSP)
3.45%
Loncar Cancer Immunotherapy ETF (CNCR)
0%
Cash & Other (Cash&Other)
0%

CNCR Technicals

Alpha

-11.3

Beta

1.78

Leverage

Long

Standard Deviation

1.42

CNCR Dividends

Dividend Date

2017-12-28

Latest Dividend

0.35

Annual Dividend

0

Annual Dividend Rate

0

Annual Dividend Yield

1.0E-5

CNCR Performance

YTD Return

-0.55%

1 Year Return

15.51%

3 Year Return

7.59%

5 Year Return

0%

10 Year Return

-15.87%

CNCR Related Articles

© 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.